VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #10 Resistance Analyses of F/TAF, F/TDF, and Lenacapavir in the PURPOSE 1 and 2 Studies – Stephanie CoxView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #9 Clearance of NNRTI Resistance-Associated Mutations in the HIV-1 DNA Reservoir with or Without the Presence of M184V Mutation - Anne-Geneviève MarcelinView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #8 Analysis of 16 Years of ARV Resistance Transmission in Newly Diagnosed HIV Cases in Spain (2007-2023): 2023 Update and the Impact of PrEP on M184V Detection - Paloma MuñozView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #7 Resistance Analysis of Long-Acting Lenacapavir in Heavily Treatment-Experienced People with HIV After 3 Years of Lenacapavir Treatment - Nicolas MargotView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #6 Lenacapavir Resistance Profile in Heavily Treatment-Experienced People in the PRESTIGIO Registry - Maria Mercedes SantoroView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #4 WG-am: A Novel Antiviral Dipeptide from Elite Controllers as a Promising Vaginal Microbicide for HIV Prevention - Rafael Ceña DiezView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #3 Unveiling Novel Microbiome Signatures for Natural Virological Control in HIV-1 Elite Controllers - Xiangning BaiView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #2 In Addition to Their Ability to Induce Resistance to Antiretrovirals, Integrase Inhibitors and Lenacapavir Resistance Mutations Enable HIV-1 to Evade Recognition by the Innate Immune System - Elisa TeyssouView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #1 Comparable Dynamics of Cell-Associated HIV-RNA, Total and Intact Proviral HIV-1 DNA in Virologically Suppressed People with HIV Switching to 2DR or Continuing 3DR Over an 18-Month Follow-Up - Lia FiaschiView Video
JAJuan AmbrosioniMD, PhDVideoHIV23rd European Meeting on HIV & Hepatitis 2025Efficacy, Toxicity and Adherence Considerations - Juan AmbrosioniView Video
JDJohn DitekemenaMD, MPH, PhDVideoTuberculosis2nd Conference on Innovations in Tuberculosis 2025Towards Integrated Prevention, Treatment, and Service Provision for TB, HIV and NCDs - John DitekemenaView Video
BdJBouke de JongMSc, PhDVideoTuberculosis2nd Conference on Innovations in Tuberculosis 2025Should Africa Move to Whole Genome Sequencing for Drug Resistance Testing? Con Standpoint - Bouke de JongView Video
